JPRN-UMIN000003512已完成2 期
Phase II study of combination chemotherapy with mitomycin and methotrexate for triple negative breast cancer - MM-TN trial
Cancer Institute Hospital, Japanese Foundation for Cancer Research0 个研究点目标入组 70 人开始时间: 2010年4月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Non invasive or microinvasive breast cancer Previously treated with chemotherapy, hormone therapy or radiotherapy Serious complication (infection, cardiac disease, pulmonary fibrosis interstitial pneumonitis, bleeding) Hepatitis type B and its carrier Pregnant, nursing or willing to be pregnant Inadequate to entry judged by investigators
研究者
相似试验
已完成
2 期
Phase II study of combination chemotherapy with cisplatin / pemetrexed / bevacizumab in patients with relapsed nonsquamous non-small cell lung cancerRelapsed nonsquamous non-small cell lung cancerJPRN-UMIN000014291St. Marianna University School of Medicine30
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30
已完成
2 期
Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumorsmedulloblastoma or supratentorial primitive neuroectodermal tumorsJPRN-UMIN000000546Japanese Pediatric Brain Tumor Consortium40
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40